BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Repligen Corporation Initiates Phase 1 Clinical Trial of RG2833 in Patients with Friedreich’s Ataxia

  March 16, 2012

   · 

  1 min read
• Business

  Synageva BioPharma Reports 2011 Full Year Financial Results

  March 16, 2012

   · 

  1 min read
• Pharm Country

  Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORA™ Oral Calcitonin

  March 16, 2012

   · 

  5 min read
• Business

  Spire Corporation Reports Results for Fourth-Quarter and Year-End 2011

  March 16, 2012

   · 

  1 min read
• Business

  Proposal of the Election Committee Regarding Members of the Board etc. for Vitrolife

  March 16, 2012

   · 

  1 min read
• Business

  Repligen Corporation Reports Financial Results for the Quarter and Nine-Month Fiscal Year Ended December 31, 2011

  March 16, 2012

   · 

  1 min read
• Business

  Prestige Brands, Inc. Comments on Genomma Lab Internacional, S.A.B. de C.V.’s Intention to Nominate Directors

  March 16, 2012

   · 

  1 min read
• Business

  Genomma Lab Internacional, S.A.B. de C.V. to Nominate Slate of Five Independent Directors for Election at Prestige Brands, Inc.’ 2012 Annual Meeting of Shareholders

  March 16, 2012

   · 

  1 min read
• Active Biotech AB Rises After “Buy” Recommendation

  March 16, 2012

   · 

  1 min read
• Business

  ImmunoCellular Therapeutics, Ltd Appoints Dr. Richard Chin to Board of Directors

  March 16, 2012

   · 

  1 min read